- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06380010
Mediterranean Diet Intervention in Adolescents With Polycystic Ovary Syndrome
April 18, 2024 updated by: Panos Papandreou, Iaso Maternity Hospital, Athens, Greece
Optimizing Dietary Habits in Adolescents With Polycystic Ovary Syndrome: Personalized Mediterranean Diet Intervention Via Clinical Decision Support System. A Randomized Controlled Trial
The aim of the present randomized controlled study was to examine wether a clinical decision support stystem would increase the adherence to the Mediterranean diet (MD) of adolescent girls, aged 15-17 years, diagnosed with polycystic ovary syndrome.
The intervention lasted for 3 months and in total, 40 girls were randomly assigned to either the MD group (n=20) or a Control group receiving general nutritional advice (n=20).
Anthropometry, nutritional intake, psychological well-being, and blood markers were analyzed at the begninning and the end of the trial.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of the present randomised controlled trial was to investigate the effects of a Mediterranean Diet (MD) intervention delivered through a Clinical Decision Support System (CDSS) on various dietary, health parameters and anxiety in adolescent females, aged 15-17 years, with PCOS.
A randomized controlled trial was conducted with 40 adolescent females diagnosed with PCOS, randomly assigned to either an Intervention group (IG) (n=20) or a Control group (CG) (n=20).
The IG received personalized dietary guidance based on the MD principles, delivered through a CDSS, while the CG received general nutritional advice.
Measurements of dietary intake, anthropometric indices, biochemical markers, and psychological well-being were collected at baseline and after a 3-month intervention period.
After 3 months, significant improvements were observed in the IG compared to the CG.
Adherence to the MD increased significantly in the IG, leading to decreased caloric intake, fat, saturated fatty acids, and dietary cholesterol, and increased intake of monounsaturated fatty acids.
Conversely, the CG experienced an increase in fat and dietary cholesterol intake.
Both groups exhibited an increase in fiber intake, with a more pronounced rise observed in the MD group.
Psychological well-being showed a significant reduction in anxiety levels in the IG group, while no significant change was observed in the CG.
The intervention led to improvements in dietary patterns, body composition, and psychological well-being.
These results underscore the importance of dietary interventions tailored to the MD principles in the management of PCOS among adolescent females.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Athens, Greece, 15123
- IASO Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Newly diagnosed with PCOS females <18 years of age.
- Females with guardians who provided signed participation consent.
Exclusion Criteria:
- Females ≥18 years of age.
- Females suffering from severe illnesses (i.e., organ failure, autoimmune diseases, congenital metabolic disorders), psychiatric disease or with emerging health issues that could hinder the trial.
- Pregnant or lactating females.
- Females diagnosed with alcoholism or drug addiction.
- Females being under any drug treatment.
- Females followed a specific type of diet within the past 5 years or have used nutrient or non-nutrient supplements within the last 6 months.
- Females with guardians non able to read and understand the consent information.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Intervention Group
Each participant was assigned to a highly skilled dietician.
The dietician implemented an individualized daily dietary regimen according to the Mediterranean diet produced by the clinical decision support system (CDSS) software.
The CDSS was utilized to calculate all necessary components for the synthesis of the dietary plan, which was renewed every 15 days.
Participants of the Intervention group obtained unique login credentials for the CDSS and received instruction on its operation from the designated dietitians.
They were directed to access their CDSS account remotely on a weekly basis in order to monitor their nutritional status (body weight and healthy eating) and to complete a three-day dietary journal; this information was automatically accessible to the dietitians.
Telephone interviews were conducted every other week in order to supplement the nutritional and lifestyle consultations.
In addition, unanticipated phone calls requesting 24-hour dietary recalls were received.
|
Females who met the inclusion and exclusion criteria were allocated in groups of one to either the Control group or the Intervention (MD) group using a random assignment method applied by an independent statistician.
During the trial, every participant in both groups had two individual sessions with the assigned researchers.
These sessions took place at the beginning of the trial and three months later, and involved anthropometry measurements, evaluation of dietary habits, assessment of psychological well-being, and collection of blood samples.
Treatment allocation was not revealed to the appointed statistician until the end of the study and release of the final outcomes.
|
No Intervention: Control Group
The Control group participants were not provided with CDSS.
They simply got basic lifestyle instructions based on the "National Dietary Guidelines for Children and Adolescents" during phone call sessions with the dieticians every 15 days.
The ladies in the Control group were directed to maintain a food diary for three consecutive days each week, which they then transmitted to the designated dietician via email.
Once again, unsolicited phone calls were conducted in order to acquire 24-hour dietary recalls.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherance to the Mediterranean diet
Time Frame: 3 months
|
Adherance was assessed with the Kidmed score
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improvement of psychological well-being
Time Frame: 3 months
|
Psychological well-being was assessed by the Hospital Anxiety-Depression Scale (HADS)
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2019
Primary Completion (Actual)
March 31, 2020
Study Completion (Actual)
June 30, 2020
Study Registration Dates
First Submitted
April 18, 2024
First Submitted That Met QC Criteria
April 18, 2024
First Posted (Actual)
April 23, 2024
Study Record Updates
Last Update Posted (Actual)
April 23, 2024
Last Update Submitted That Met QC Criteria
April 18, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Neoplasms
- Endocrine System Diseases
- Disease
- Ovarian Cysts
- Cysts
- Ovarian Diseases
- Adnexal Diseases
- Gonadal Disorders
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Genital Diseases
- Genital Diseases, Female
- Polycystic Ovary Syndrome
- Syndrome
Other Study ID Numbers
- IASO HOSPITAL (ATHENS-GREECE)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polycystic Ovary Syndrome
-
Cairo UniversityCompleted
-
Alexandria UniversityRecruitingPolycystic Ovary Syndrome (PCOS)Egypt
-
Saudi German Hospital - MadinahCompletedPolycystic Ovary Syndrome (PCOS)Saudi Arabia
-
University of CopenhagenCompletedPolycystic Ovary Syndrome (PCOS)Denmark
-
Odense University HospitalCompleted
-
Assaf-Harofeh Medical CenterUnknownInfertility | Polycystic OvariesIsrael
-
Poznan University of Medical SciencesUniversity of California, DavisUnknownPolycystic Ovary Syndrome (PCOS)Poland
-
Riphah International UniversityCompleted
-
Dexa Medica GroupCompletedPolycystic Ovary Syndrome (PCOS)Indonesia
-
Virginia Commonwealth UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedPolycystic Ovary Syndrome (PCOS)United States
Clinical Trials on Mediterranean diet group
-
University of CreteCompletedObstructive Sleep Apnoea | Hypopnoea SyndromeGreece
-
Clinica Alemana de SantiagoComisión Nacional de Investigación Científica y TecnológicaCompletedStroke, Ischemic | Stroke, AcuteChile
-
Washington University School of MedicineCompletedHypertension | Overweight | Glucose Intolerance | Hypercholesterolemia | Pre-hypertensionUnited States
-
University of ChileFondo Nacional de Desarrollo Científico y Tecnológico, ChileTerminatedMetabolic SyndromeChile
-
Purdue UniversityMushroom CouncilCompleted
-
Hippocration General HospitalCompleted
-
University of East AngliaNewcastle UniversityRecruitingDepression, AnxietyUnited Kingdom
-
University of California, IrvineCompletedPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myeloproliferative Disorder | Myeloproliferative SyndromeUnited States
-
Gangnam Severance HospitalUnknown
-
Federico II UniversityCompletedMediterranean Diet | Neuroendocrine Tumours (NETs)Italy